- $1.09bn
- $969.12m
- $348.88m
- 87
- 49
- 72
- 79
Annual balance sheet for MiMedx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 95.8 | 87.1 | 66 | 82 | 104 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 45.5 | 41.1 | 43.8 | 53.9 | 55.8 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 161 | 149 | 134 | 164 | 192 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 15.1 | 13.9 | 11.3 | 9.11 | 11.6 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 202 | 188 | 171 | 239 | 264 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 59.2 | 42.4 | 43.6 | 46 | 45.6 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 111 | 95.4 | 96.9 | 96.3 | 70.8 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 91.4 | 92.6 | 74.5 | 143 | 193 |
| Total Liabilities & Shareholders' Equity | 202 | 188 | 171 | 239 | 264 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |